Market
27 Nov 2023
SRP in brief: Roche and roll
The spotlight is on Switzerland as over 75% of live products featuring the Roche share are more than 10% away from crossing their Knock-In barriers. Some 55% are more than 20% from breaching them.
Market
20 Nov 2023
SRP in brief: junk fees and barriers
Regulatory developments in Germany and the US, turnover in Switzerland, and in-house SRP research on products linked to HSCEI and Roche.
Products
15 Nov 2023
Roche: most defensive barriers at safe distance as stock struggles
More than 75% of live products featuring the Swiss share are more than 10% away from crossing their Knock-In barriers; 55% at more than 20% from breaching them.